PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does Pharmacielo Ltd (PCLO) operate in?
Pharmacielo Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Pharmacielo Ltd (PCLO) current stock price?
As of the latest data, Pharmacielo Ltd stock price is CA$0.05, with a previous close of CA$0.05.
What is Pharmacielo Ltd (PCLO) current market capitalization?
Pharmacielo Ltd market cap is approximately 10.01 million.
What is Pharmacielo Ltd (PCLO) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.02.
What is Pharmacielo Ltd (PCLO) EBITDA?
Pharmacielo Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -661.30 thousand.
Does Pharmacielo Ltd (PCLO) pay dividends?
No. Pharmacielo Ltd does not pay a dividend.
When is Pharmacielo Ltd (PCLO) next earnings report?
Pharmacielo Ltd is expected to release its next earnings report on September 30, 2026.
What is Pharmacielo Ltd (PCLO) beta (volatility) score?
Pharmacielo Ltd has a beta of 0.619, indicating lower volatility than the overall market.